Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$29.67 - $60.28 $133,574 - $271,380
-4,502 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$47.84 - $64.34 $9,472 - $12,739
-198 Reduced 4.21%
4,502 $263,000
Q3 2021

Nov 10, 2021

SELL
$59.27 - $95.73 $7,705 - $12,444
-130 Reduced 2.69%
4,700 $279,000
Q2 2021

Aug 09, 2021

SELL
$67.25 - $92.52 $134 - $185
-2 Reduced 0.04%
4,830 $419,000
Q1 2021

May 14, 2021

SELL
$72.16 - $117.4 $1,659 - $2,700
-23 Reduced 0.47%
4,832 $398,000
Q4 2020

Feb 11, 2021

BUY
$38.09 - $100.95 $175,214 - $464,370
4,600 Added 1803.92%
4,855 $441,000
Q2 2020

Aug 13, 2020

BUY
$20.21 - $35.23 $5,153 - $8,983
255 New
255 $9,000
Q1 2020

May 13, 2020

SELL
$17.28 - $31.88 $4,406 - $8,129
-255 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$13.39 - $20.73 $3,414 - $5,286
255 New
255 $5,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $99.9M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.